The prevalence of healthcare-associated infections (HAIs) in the NHS hospitals, community and primary care services continues unabated, increasing costs, morbidity and causing profound patient dissatisfaction. Following the introduction of healthcare governance in the NHS, the need to develop more clinically effective approaches to preventing infections has become urgent. National evidence-based guidelines are now being developed and implemented in NHS Trusts in England. The experience of developing and implementing these guidelines is described, along with other initiatives designed to enhance the evidence base for infection prevention and control.
Get full access to this article
View all access options for this article.
References
1.
MeersPDGAAyliffeEmmersonAM Report on the national survey of infection in hospitals 1980. J Hosp Infect (Suppl) 1981; 2:1-11.
2.
EmmersonAMJEEnstoneGriffinM The second national prevalence survey of infection in hospitals - an overview of results. J Hosp Infect 1996; 32: 175-90.
3.
PlowmanRNGravesGriffinM The socio-economic burden of hospital-acquired infection. London: Public Health Laboratory Service and The London School of Hygiene and Tropical Medicine; 1999.
4.
Department of Health and the Public Health Laboratory Service. Hospital infection control: guidance on the control of infections in hospitals. HSG(95)10. London: Department of Health; 1995.
5.
Report by the Comptroller and Auditor General - HC 230 Session 1999-2000. The management and control of hospital acquired infection in acute NHS Trusts in England. London:The Stationery Office Ltd; 2000.
6.
House of Commons. Committee of Public Accounts Session 1999-2000. Forty-second report: the management and control of hospital acquired infections in acute NHS trusts in England, together with the proceedings of the Committee relating to the report, the minutes of evidence and appendices. London:The Stationery Office; 2000.
7.
National Health Service Executive. Promoting clinical excellence: a framework for action in and through the NHS. Leeds: Department of Health; 1996; 44.
8.
PelloweCMEDMacRaeLovedayHP The scope of guidelines to prevent health-care-associated infections. B J Community Nurs 2002; 7(7):374-8.
9.
CluzeauFLittlejohns P GrimshawJAppraisal instrument for clinical guidelines (Version I). St George’s Hospital Medica. School, London, May (1997). Now: The AGREE Collaboration. Appraisal of Guidelines for Research &Evaluation (AGREE) Instrument. June2001. (http://www.agreecollaboration.org/)
10.
PrattRJCPelloweLovedayHP and the epic guideline development team; Barrett S, Davey P Harper P Loveday C, McDougall C, Mulhall A, Privett S, Smales C,Taylor L,Weller B, and Wilcox M. (2001a). The epic project: developing national evidence-based guidelines for preventing healthcare associated infections. Phase I: guidelines for preventing hospital-acquired infections. J Hosp Infect 2001; 47(Suppl): 1-82.
11.
GrimshawJNFreemantle,Wallace S Developing and implementing clinical practice guidelines. Int J Qual Health Care 1995;41(1):55-64.
12.
PrattRJCPelloweJuvekarSK Kaleidoscope - a five year action research project to develop nursing confidence in caring for patients with HIV disease in west India. Int Nurs Rev 2001; 48(3): 164-73.
13.
Loveday HP Harper PJ, Mulhall A Informing the future- a review of nursing roles and responsibilities in community infection control - Part I. British Journal of Infection Control 2002; 3(6):20-4.
14.
LovedayHPPJHarperMulhallA Informing the future- a review of nursing roles and responsibilities in community infection control - Part 2. British Journal of Infection Control 2003; 4(1):20-3.
